Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Eldorado Gold
EGO
$5.32B
| $52.8M | 0.04% |
6,572,769
+580,700
| +10% | +$4.66M |
|
502
National Bank Holdings
NBHC
$1.47B
| $52.8M | 0.04% |
1,498,300
-47,900
| -3% | -$1.69M |
|
|
MGLN
503
DELISTED
Magellan Health Services, Inc.
MGLN
| $52.7M | 0.04% |
673,819
+40,020
| +6% | +$3.13M |
|
504
First Industrial Realty Trust
FR
$6.79B
| $52.6M | 0.04% |
1,266,500
-590,300
| -32% | -$24.5M |
|
505
Hilton Worldwide
HLT
$64.7B
| $52.5M | 0.04% |
473,700
+120,600
| +34% | +$13.4M |
|
506
Cintas
CTAS
$81.4B
| $52.5M | 0.04% |
780,272
-882,800
| -53% | -$59.4M |
|
507
Delta Air Lines
DAL
$39.6B
| $52.4M | 0.04% |
895,200
-846,600
| -49% | -$49.5M |
|
508
Grupo Aeroportuario Centro Norte
OMAB
$5.18B
| $52.3M | 0.04% |
873,000
+72,500
| +9% | +$4.35M |
|
509
Coca-Cola
KO
$292B
| $52.1M | 0.04% |
940,600
-1,923,500
| -67% | -$106M |
|
510
MGIC Investment
MTG
$6.51B
| $51.7M | 0.04% |
3,647,500
-1,853,500
| -34% | -$26.3M |
|
|
AGR
511
DELISTED
Avangrid, Inc.
AGR
| $51.7M | 0.04% |
1,009,855
-92,900
| -8% | -$4.75M |
|
|
ENIA
512
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $51.5M | 0.04% |
4,690,400
+288,100
| +7% | +$3.16M |
|
|
MDCO
513
DELISTED
Medicines Co
MDCO
| $51.4M | 0.04% |
605,132
-419,600
| -41% | -$35.6M |
|
|
SNR
514
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $51.4M | 0.04% |
6,713,309
+256,739
| +4% | +$1.96M |
|
515
Hamilton Lane
HLNE
$6.49B
| $50.8M | 0.04% |
852,600
-17,700
| -2% | -$1.05M |
|
516
Ciena
CIEN
$17.3B
| $50.5M | 0.04% |
1,182,074
+383,300
| +48% | +$16.4M |
|
517
Chefs' Warehouse
CHEF
$2.63B
| $50.3M | 0.04% |
1,320,700
-35,600
| -3% | -$1.36M |
|
518
RE/MAX Holdings
RMAX
$187M
| $50.3M | 0.04% |
1,306,700
+52,300
| +4% | +$2.01M |
|
519
JB Hunt Transport Services
JBHT
$13.6B
| $50.3M | 0.04% |
430,644
+347,600
| +419% | +$40.6M |
|
520
CNA Financial
CNA
$12.8B
| $50.3M | 0.04% |
1,121,400
+95,200
| +9% | +$4.27M |
|
521
Wolfspeed
WOLF
$285M
| $50M | 0.04% |
1,082,532
+9,790
| +0.9% | +$452K |
|
522
Canadian National Railway
CNI
$58.2B
| $49.8M | 0.04% |
550,702
+247,002
| +81% | +$22.3M |
|
523
Booz Allen Hamilton
BAH
$12.7B
| $49.7M | 0.04% |
698,894
+98,900
| +16% | +$7.03M |
|
524
OneMain Financial
OMF
$7.23B
| $49.6M | 0.04% |
1,175,600
-7,097
| -0.6% | -$299K |
|
|
RETA
525
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $49.5M | 0.04% |
+242,100
| New | +$49.5M |
|